Literature DB >> 20424967

Contrast echocardiography: what have we learned from the new guidelines?

Kevin Wei1.   

Abstract

A new consensus statement on the clinical applications of ultrasound contrast agents was published in November 2008 in the Journal of the American Society of Echocardiography. These guidelines provide the rationale for contrast use, and specifically highlight a number of clinical scenarios in which contrast should always be considered. These include the 1) assessment of left ventricular (LV) systolic function--especially when quantitative LV volumes and ejection fraction, or serial assessments are required, and during stress echocardiography; 2) evaluation of the LV apex; 3) evaluation of mechanical complications of myocardial infarction; 4) evaluation of suspected intracardiac mass; and 5) to enhance Doppler signals in the systemic circulation. Furthermore, detailed outlines on contrast administration, logistics, personnel requirements, and responsibilities are provided. Recent data published in the past 2 years to support these recommendations, and contrast agent safety data, are reviewed in this article.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424967     DOI: 10.1007/s11886-010-0105-x

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  10 in total

1.  Usefulness of ultrasound contrast agent to improve image quality during real-time three-dimensional stress echocardiography.

Authors:  Attila Nemes; Marcel L Geleijnse; Boudewijn J Krenning; Osama I I Soliman; Ashraf M Anwar; Wim B Vletter; Folkert J Ten Cate
Journal:  Am J Cardiol       Date:  2006-11-27       Impact factor: 2.778

2.  The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses.

Authors:  Kevin Wei; Sharon L Mulvagh; Lisa Carson; Ravin Davidoff; Ruvin Gabriel; Richard A Grimm; Stephanie Wilson; Lorrie Fane; Charles A Herzog; William A Zoghbi; Rhonda Taylor; Michael Farrar; Farooq A Chaudhry; Thomas R Porter; Waleed Irani; Roberto M Lang
Journal:  J Am Soc Echocardiogr       Date:  2008-10-10       Impact factor: 5.251

Review 3.  Contrast echocardiography: current and future applications.

Authors:  S L Mulvagh; A N DeMaria; S B Feinstein; P N Burns; S Kaul; J G Miller; M Monaghan; T R Porter; L J Shaw; F S Villanueva
Journal:  J Am Soc Echocardiogr       Date:  2000-04       Impact factor: 5.251

4.  American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography.

Authors:  Sharon L Mulvagh; Harry Rakowski; Mani A Vannan; Sahar S Abdelmoneim; Harald Becher; S Michelle Bierig; Peter N Burns; Ramon Castello; Patrick D Coon; Mary E Hagen; James G Jollis; Thomas R Kimball; Dalane W Kitzman; Itzhak Kronzon; Arthur J Labovitz; Roberto M Lang; Joseph Mathew; W Stuart Moir; Sherif F Nagueh; Alan S Pearlman; Julio E Perez; Thomas R Porter; Judy Rosenbloom; G Monet Strachan; Srihari Thanigaraj; Kevin Wei; Anna Woo; Eric H C Yu; William A Zoghbi
Journal:  J Am Soc Echocardiogr       Date:  2008-11       Impact factor: 5.251

5.  Usefulness of contrast echocardiography for assessment of left ventricular thrombus after acute myocardial infarction.

Authors:  Nicolas Mansencal; Imad Abi Nasr; Rémy Pillière; Jean-Christian Farcot; Thierry Joseph; Pascal Lacombe; Olivier Dubourg
Journal:  Am J Cardiol       Date:  2007-05-02       Impact factor: 2.778

6.  Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies.

Authors:  Lisa L Kusnetzky; Adnan Khalid; Taiyeb M Khumri; Tabitha G Moe; Philip G Jones; Michael L Main
Journal:  J Am Coll Cardiol       Date:  2008-04-09       Impact factor: 24.094

7.  Cost-efficiency of myocardial contrast echocardiography in patients presenting to the emergency department with chest pain of suspected cardiac origin and a nondiagnostic electrocardiogram.

Authors:  Jared J Wyrick; Saul Kalvaitis; K John McConnell; Diana Rinkevich; Sanjiv Kaul; Kevin Wei
Journal:  Am J Cardiol       Date:  2008-07-09       Impact factor: 2.778

8.  Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients).

Authors:  Michael L Main; Amy C Ryan; Teresa E Davis; Maureen P Albano; Lisa L Kusnetzky; Mark Hibberd
Journal:  Am J Cardiol       Date:  2008-10-23       Impact factor: 2.778

9.  Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort.

Authors:  Mustafa Kurt; Kamran A Shaikh; Leif Peterson; Karla M Kurrelmeyer; Gopi Shah; Sherif F Nagueh; Robert Fromm; Miguel A Quinones; William A Zoghbi
Journal:  J Am Coll Cardiol       Date:  2009-03-03       Impact factor: 24.094

10.  Comparison of contrast enhanced three dimensional echocardiography with MIBI gated SPECT for the evaluation of left ventricular function.

Authors:  Bernard Cosyns; David Haberman; Steven Droogmans; Sandrine Warzée; Philippe Mahieu; Eric Laurent; Marie Moonen; Sophie Hernot; Patrizio Lancellotti
Journal:  Cardiovasc Ultrasound       Date:  2009-06-16       Impact factor: 2.062

  10 in total
  3 in total

1.  Contrast-enhanced sonography of malignant pediatric abdominal and pelvic solid tumors: preliminary safety and feasibility data.

Authors:  M Beth McCarville; Sue C Kaste; Fredric A Hoffer; Raja B Khan; R Christopher Walton; Bruce S Alpert; Wayne L Furman; Chenghong Li; Xiaoping Xiong
Journal:  Pediatr Radiol       Date:  2012-01-17

Review 2.  Contrast-enhanced sonography in pediatrics.

Authors:  M Beth McCarville
Journal:  Pediatr Radiol       Date:  2011-04-27

Review 3.  Recent advances in molecular, multimodal and theranostic ultrasound imaging.

Authors:  Fabian Kiessling; Stanley Fokong; Jessica Bzyl; Wiltrud Lederle; Moritz Palmowski; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2013-12-04       Impact factor: 15.470

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.